- Home
- Publications
- Publication Search
- Publication Details
Title
MicroRNA signature refine response prediction in CML
Authors
Keywords
-
Journal
Scientific Reports
Volume 9, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-07-04
DOI
10.1038/s41598-019-46132-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MicroRNA21 and the various types of myeloid leukemia
- (2018) Mani Panagal et al. CANCER GENE THERAPY
- Upregulation of microRNA-21 is a poor prognostic marker in patients with childhood B cell acute lymphoblastic leukemia
- (2017) Hany Abedelmalik Labib et al. Hematology
- MiR-26 enhances chemosensitivity and promotes apoptosis of hepatocellular carcinoma cells through inhibiting autophagy
- (2017) Fangfang Jin et al. Cell Death & Disease
- Regulation of multidrug resistance by microRNAs in anti-cancer therapy
- (2017) Xin An et al. Acta Pharmaceutica Sinica B
- Downregulation of miR-451 in Tunisian chronic myeloid leukemia patients: potential implication in imatinib resistance
- (2016) Ismael Soltani et al. Hematology
- miRNAs in chronic myeloid leukemia: small molecules, essential function
- (2016) Zofia Litwińska et al. LEUKEMIA & LYMPHOMA
- Clinical significance of microRNAs in chronic and acute human leukemia
- (2016) Chien-Hung Yeh et al. Molecular Cancer
- miRNAs as Biomarkers in Chronic Myelogenous Leukemia
- (2015) Kasuen Kotagama et al. DRUG DEVELOPMENT RESEARCH
- miR expression profiling at diagnosis predicts relapse in pediatric precursor B-cell acute lymphoblastic leukemia
- (2015) Smadar Avigad et al. GENES CHROMOSOMES & CANCER
- Chronic myeloid leukaemia
- (2015) Jane F Apperley LANCET
- Prognosis of long-term survival considering disease-specific death in patients with chronic myeloid leukemia
- (2015) M Pfirrmann et al. LEUKEMIA
- Drug transporters play a key role in the complex process of Imatinib resistance in vitro
- (2015) Raquel Alves et al. LEUKEMIA RESEARCH
- Curcumin inhibits in vitro and in vivo chronic myelogenous leukemia cells growth: a possible role for exosomal disposal of miR-21
- (2015) Simona Taverna et al. Oncotarget
- MicroRNA-320a acts as a tumor suppressor by targeting BCR/ABL oncogene in chronic myeloid leukemia
- (2015) Zhu Xishan et al. Scientific Reports
- Targeting miR-21 sensitizes Ph+ ALL Sup-b15 cells to imatinib-induced apoptosis through upregulation of PTEN
- (2014) Wei-Zhang Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- ApoptomiRs expression modulated by BCR–ABL is linked to CML progression and imatinib resistance
- (2014) A.F. Ferreira et al. BLOOD CELLS MOLECULES AND DISEASES
- MicroRNAome genome: A treasure for cancer diagnosis and therapy
- (2014) Ioana Berindan-Neagoe et al. CA-A CANCER JOURNAL FOR CLINICIANS
- European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013
- (2013) M. Baccarani et al. BLOOD
- MicroRNAs in myeloid malignancies
- (2013) Jane E. A. Gordon et al. BRITISH JOURNAL OF HAEMATOLOGY
- MiRNA-26b inhibits proliferation by targeting PTGS2 in breast cancer
- (2013) Jia Li et al. Cancer Cell International
- Functional screen analysis reveals miR-26b and miR-128 as central regulators of pituitary somatomammotrophic tumor growth through activation of the PTEN–AKT pathway
- (2012) T Palumbo et al. ONCOGENE
- Predicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment: the EUTOS score
- (2011) J. Hasford et al. BLOOD
- miRNAs and regulation of cell signaling
- (2011) Atsuhiko Ichimura et al. FEBS Journal
- MicroRNA-451 in chronic myeloid leukemia: miR-451–BCR-ABL regulatory loop?
- (2011) Tereza Lopotová et al. LEUKEMIA RESEARCH
- miRNA-451: A putative predictor marker of Imatinib therapy response in chronic myeloid leukemia
- (2011) Vanesa Scholl et al. LEUKEMIA RESEARCH
- MiRNA-451 plays a role as tumor suppressor in human glioma cells
- (2010) Yang Nan et al. BRAIN RESEARCH
- Anti-miR-21 oligonucleotide sensitizes leukemic K562 cells to arsenic trioxide by inducing apoptosis
- (2010) Yumin Li et al. CANCER SCIENCE
- Involvement of miR-21 in resistance to daunorubicin by regulating PTEN expression in the leukaemia K562 cell line
- (2010) Haitao Bai et al. FEBS LETTERS
- MicroRNAs and cancer—new paradigms in molecular oncology
- (2009) Massimo Negrini et al. CURRENT OPINION IN CELL BIOLOGY
- Imatinib resistance in CML
- (2008) Gisella Volpe et al. CANCER LETTERS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started